South Street Advisors’s AbbVie ABBV Stock Holding History

South Street Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.13M	Buy	14,391 +420	+3%	+$93.2K	0.45%	36
2025 Q4	$3.19M	Buy	13,971 +1,345	+11%	+$306K	0.45%	37
2025 Q3	$2.92M	Buy	12,626 +1,153	+10%	+$235K	0.38%	38
2025 Q2	$2.13M	Sell	11,473 -1,103	-9%	-$205K	0.32%	41
2025 Q1	$2.63M	Sell	12,576 -138	-1%	-$26.8K	0.43%	39
2024 Q4	$2.26M	Sell	12,714 -1,247	-9%	-$229K	0.35%	42
2024 Q3	$2.76M	Hold	13,961	–	–	0.42%	41
2024 Q2	$2.39M	Sell	13,961 -389	-3%	-$64.4K	0.36%	41
2024 Q1	$2.61M	Sell	14,350 -890	-6%	-$153K	0.42%	39
2023 Q4	$2.36M	Hold	15,240	–	–	0.44%	40
2023 Q3	$2.27M	Hold	15,240	–	–	0.46%	41
2023 Q2	$2.05M	Sell	15,240 -2,710	-15%	-$397K	0.41%	41
2023 Q1	$2.86M	Hold	17,950	–	–	0.59%	35
2022 Q4	$2.9M	Hold	17,950	–	–	0.64%	32
2022 Q3	$2.41M	Sell	17,950 -516	-3%	-$74K	0.59%	36
2022 Q2	$2.83M	Sell	18,466 -220	-1%	-$33.6K	0.64%	34
2022 Q1	$3.03M	Sell	18,686 -400	-2%	-$58.1K	0.57%	36
2021 Q4	$2.58M	Sell	19,086 -1,766	-8%	-$209K	0.45%	35
2021 Q3	$2.25M	Hold	20,852	–	–	0.43%	37
2021 Q2	$2.35M	Sell	20,852 -476	-2%	-$53.6K	0.44%	34
2021 Q1	$2.31M	Sell	21,328 -1,845	-8%	-$197K	0.73%	19
2020 Q4	$2.48M	Sell	23,173 -10,026	-30%	-$963K	0.53%	30
2020 Q3	$2.91M	Hold	33,199	–	–	0.7%	27
2020 Q2	$3.26M	Buy	33,199 +20,409	+160%	+$1.8M	0.87%	26
2020 Q1	$974K	Hold	12,790	–	–	0.32%	33
2019 Q4	$1.13M	Hold	12,790	–	–	0.29%	36
2019 Q3	$968K	Hold	12,790	–	–	0.28%	38
2019 Q2	$930K	Sell	12,790 -1,000	-7%	-$78.6K	0.28%	41
2019 Q1	$1.11M	Sell	13,790 -131,474	-91%	-$10.8M	0.34%	39
2018 Q4	$13.4M	Sell	145,264 -1,296	-0.9%	-$114K	4.73%	3
2018 Q3	$13.9K	Sell	146,560 -1,935	-1%	-$183K	2.16%	8
2018 Q2	$13.8M	Sell	148,495 -2,660	-2%	-$260K	4.17%	6
2018 Q1	$14.3K	Sell	151,155 -4,870	-3%	-$535K	1.42%	8
2017 Q4	$15.1M	Sell	156,025 -6,880	-4%	-$648K	4.57%	3
2017 Q3	$14.5K	Sell	162,905 -2,600	-2%	-$198K	2.81%	5
2017 Q2	$12M	Sell	165,505 -310	-0.2%	-$20.8K	3.93%	6
2017 Q1	$10.8K	Sell	165,815 -800	-0.5%	-$50.3K	1.49%	13
2016 Q4	$10.4M	Sell	166,615 -24,705	-13%	-$1.51M	3.68%	10
2016 Q3	$12.1M	Buy	191,320 +30,790	+19%	+$1.99M	3.73%	9
2016 Q2	$9.94M	Buy	160,530 +122,305	+320%	+$7.45M	3.13%	18
2016 Q1	$2.18M	Sell	38,225 -30	-0.1%	-$1.67K	0.72%	28
2015 Q4	$2.26M	Sell	38,255 -220	-0.6%	-$12.7K	0.72%	29
2015 Q3	$2.09M	Buy	38,475 +505	+1%	+$32.9K	0.71%	32
2015 Q2	$2.55M	Sell	37,970 -9,320	-20%	-$608K	0.8%	30
2015 Q1	$2.77K	Buy	47,290 +3,470	+8%	+$210K	0.82%	32
2014 Q4	$2.87M	Hold	43,820	–	–	0.95%	30
2014 Q3	$2.53M	Buy	43,820 +4,800	+12%	+$266K	0.92%	31
2014 Q2	$2.2K	Sell	39,020 -200	-0.5%	-$10.5K	0.62%	33
2014 Q1	$2.02M	Hold	39,220	–	–	0.8%	31
2013 Q4	$2.07M	Hold	39,220	–	–	0.87%	31
2013 Q3	$1.75M	Buy	39,220 +1,120	+3%	+$49.6K	0.84%	31
2013 Q2	$1.57M	Buy	+38,100	New	+$1.67M	0.83%	30

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

South Street Advisors's ABBV Position: Q1 2026 in Review

South Street Advisors increased its AbbVie (ABBV) stake by 3% in Q1 2026, buying an estimated $93.2K and bringing the position to 14,391 shares worth $3.13M. The position accounts for 0.45% of the portfolio, ranked #36.

South Street Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.1M in Q4 2017. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

South Street Advisors held 14,391 shares of AbbVie worth $3.13M as of Q1 2026.
South Street Advisors bought 420 AbbVie shares in Q1 2026, an estimated $93.2K.
AbbVie made up 0.45% of South Street Advisors's portfolio in Q1 2026, its #36 holding.
South Street Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
South Street Advisors's AbbVie position peaked at $15.1M in Q4 2017.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on South Street Advisors's 13F filing for Q1 2026, filed 13 May 2026.